These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 6226465

  • 21. Impairment of concanavalin A-inducible suppressor activity following administration of cyclophosphamide to patients with advanced cancer.
    Berd D, Maguire HC, Mastrangelo MJ.
    Cancer Res; 1984 Mar; 44(3):1275-80. PubMed ID: 6229330
    [Abstract] [Full Text] [Related]

  • 22. Blood mononuclear cells with suppressor activity in patients with thyroid disorders: increased levels of T gamma cells in subacute thyroiditis.
    Wall JR, Chartier B.
    J Clin Lab Immunol; 1981 Sep; 6(2):115-9. PubMed ID: 6457155
    [Abstract] [Full Text] [Related]

  • 23. Suppressor lymphocytes during open heart surgery.
    Salo M, Soppi E, Lassila O, Ruuskanen O.
    J Clin Lab Immunol; 1981 May; 5(3):159-63. PubMed ID: 6454000
    [Abstract] [Full Text] [Related]

  • 24. Functional heterogeneities among concanavalin A-activated OKT4+ and OKT8+ cells by using autologous erythrocyte rosette technique.
    Takada S, Ueda Y, Murakawa Y, Suzuki N, Sakane T.
    J Clin Invest; 1983 Dec; 72(6):2060-71. PubMed ID: 6227636
    [Abstract] [Full Text] [Related]

  • 25. Virus-specific effector CD4+ T-cell responses in hemodialysis patients with hepatitis C virus infection.
    Rico MA, Ruiz S, Subirá D, Barril G, Cigarrán S, Castañón S, Quiroga JA, Selgas R, Carreño V.
    J Med Virol; 2004 Jan; 72(1):66-74. PubMed ID: 14635013
    [Abstract] [Full Text] [Related]

  • 26. Effect of plasmapheresis on cellular immunity abnormalities in patients with systemic lupus erythematosus.
    Bonomini V, Vangelista A, Frascà GM, Nanni-Costa A, Borgnino LC.
    Clin Nephrol; 1984 Sep; 22(3):121-6. PubMed ID: 6237815
    [Abstract] [Full Text] [Related]

  • 27. Immune alterations in hemodialyzed patients. I. Effect of blood transfusion on T-lymphocyte subpopulations in hemodialyzed patients.
    Nanishi F, Inenaga T, Onoyama K, Oh Y, Oochi N, Fujishima M.
    J Clin Lab Immunol; 1986 Apr; 19(4):167-74. PubMed ID: 2941588
    [Abstract] [Full Text] [Related]

  • 28. Inability of newborns' or pregnant women's monocytes to suppress pokeweed mitogen-induced responses.
    Durandy A, Fischer A, Griscelli C.
    J Immunol; 1982 Feb; 128(2):525-9. PubMed ID: 6459380
    [Abstract] [Full Text] [Related]

  • 29. [Effect of levamisole on the activity of the blood T-lymphocytes and of factors they produce in patients with laryngeal cancer].
    Volosevich LI, Lukach EV, Krivokhatskaia LD.
    Eksp Onkol; 1988 Feb; 10(3):54-7. PubMed ID: 2970382
    [Abstract] [Full Text] [Related]

  • 30. Increased sensitivity to concanavalin A and a suppressor cell defect in chronic active hepatitis.
    de Galocsy C, Jenkins PJ, Mieli-Vergani G, Eddleston AL, Williams R.
    Clin Exp Immunol; 1981 Mar; 43(3):486-90. PubMed ID: 6456855
    [Abstract] [Full Text] [Related]

  • 31. Immunological suppressor cell activity in insulin dependent diabetes.
    Slater LM, Murray SL, Kershnar A, Mosier MA.
    J Clin Lab Immunol; 1980 Mar; 3(2):105-9. PubMed ID: 6451707
    [Abstract] [Full Text] [Related]

  • 32. Subpopulations of T lymphocytes and non-specific suppressor cell activity in patients with atopic dermatitis.
    Jensen JR, Cramers M, Thestrup-Pedersen K.
    Clin Exp Immunol; 1981 Jul; 45(1):118-23. PubMed ID: 6458433
    [Abstract] [Full Text] [Related]

  • 33. [Suppressor T-lymphocytes in continuously progressive juvenile schizophrenia].
    Maznina TP, Mikheeva TV, Lavrov VF, Abramova LI, Koliaskina GI.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984 Jul; 84(7):1065-9. PubMed ID: 6236659
    [Abstract] [Full Text] [Related]

  • 34. Functional suppressor T cell activity in Crohn's disease and the effects of sulphasalazine.
    Holdstock G, Chastenay BF, Krawitt EL.
    Clin Exp Immunol; 1982 Jun; 48(3):619-24. PubMed ID: 6126286
    [Abstract] [Full Text] [Related]

  • 35. Indomethacin sensitive suppressor cells in Crohn's disease: a possible role in decreased lymphocyte responsiveness.
    Victorino RM.
    J Clin Lab Immunol; 1983 Aug; 11(4):197-201. PubMed ID: 6230454
    [Abstract] [Full Text] [Related]

  • 36. Role of prostaglandin E2 in the induction of nonspecific T lymphocyte suppressor activity.
    Fischer A, Durandy A, Griscelli C.
    J Immunol; 1981 Apr; 126(4):1452-5. PubMed ID: 6451647
    [Abstract] [Full Text] [Related]

  • 37. Haemodialysis, continuous ambulatory peritoneal dialysis and cellular immunity.
    Collart F, Tielemans C, Dratwa M, Schandene L, Wybran J, Dupont E.
    Proc Eur Dial Transplant Assoc; 1983 Apr; 20():190-4. PubMed ID: 6228939
    [Abstract] [Full Text] [Related]

  • 38. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [Abstract] [Full Text] [Related]

  • 39. Immunoregulation in Sjögren's syndrome: influence of serum factors on T-cell subpopulations.
    Moutsopoulos HM, Fauci AS.
    J Clin Invest; 1980 Feb; 65(2):519-28. PubMed ID: 6444308
    [Abstract] [Full Text] [Related]

  • 40. Induction of suppressor cell activities in normal lymphocytes by sera from gastric cancer patients.
    Toge T, Tanada M, Yajima K, Kohno H, Itagaki E, Hattori T.
    Clin Exp Immunol; 1983 Oct; 54(1):80-6. PubMed ID: 6225584
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.